If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
162.80    0.60 (0.37%)
Bid:
161.00
Ask:
162.80
Spread: 1.80 (1.118%)
Market Cap: £277.18m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Board Update

6 Sep 2022 14:51

RNS Number : 4831Y
McBride PLC
06 September 2022
 

6 September 2022

 

McBride plc

 

("McBride" or the "Company)

 

Board Update - Notification under Listing Rule 9.6.11(3)

 

McBride, the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, announced on 18 February 2022, that Steve Hannam would be stepping down from the Board immediately following the annual general meeting ("AGM") on 18th October 2022.

 

The date for the AGM has now been changed to 16th November 2022. Mr Hannam will continue in his role until immediately after the AGM on the revised date.

 

In accordance with Listing Rule 9.6.11(3), McBride announces the following changes in Board roles and responsibilities.

 

The Company is pleased to announce that Elizabeth McMeikan, currently a Non-Executive Director of McBride, will be appointed as Senior Independent Director with effect from the end of the AGM. Elizabeth will bring a wealth of experience to this additional role.

 

We are also delighted to announce that Regi Aalstad, currently a Non-Executive Director of McBride, will be taking on the role of Designated Non-Executive Director for Employee Engagement, continuing Steve Hannam's good work in this area once he has stepped down from the Board.

 

Jeff Nodland, Chairman of McBride plc, commented:

 

"The Board is committed to ensuring that the Company maintains high standards of corporate governance with orderly succession and rotation of Board roles and responsibilities. These changes take into account our Non-Executive Directors' skills, knowledge and experience and their enthusiasm to take on new responsibilities during the next stage of McBride's growth. Once again, I would like to thank Steve for his wise counsel over the past nine years and wish him the very best for the future."

 

 

McBride plc

 

Jeff Nodland, Chairman

0161 203 7570

Chris Smith, CEO

FTI Consulting

 

Ed Bridges, Nick Hasell

020 3727 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSUFDMEESELU
Date   Source Headline
1st Dec 20257:00 amRNSLaunch of share buyback programme
28th Nov 20256:29 pmRNSRedemption of B Shares and Total Voting Rights
27th Nov 202512:27 pmRNSHolding(s) in Company
25th Nov 20257:00 amRNSHolding(s) in Company
20th Nov 20254:40 pmRNSAGM Statement
20th Nov 20257:00 amRNSAGM Trading Update and Share Buyback
18th Nov 20259:42 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20256:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSApplication for Additional Listing of Shares
17th Oct 20256:23 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSRedemption of B Shares
19th Sep 20257:00 amRNSDirector/PDMR Shareholding
18th Sep 20259:04 amRNSEx-dividend date - Correction
17th Sep 20257:00 amRNSFinal Results
5th Sep 20257:00 amRNS-RInvestor Webinar on 18 September 2025
16th Jul 20257:00 amRNSFull Year Trading Update
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSHolding(s) in Company
29th May 20253:19 pmRNSHolding(s) in Company
23rd May 20251:42 pmRNSHolding(s) in Company
19th May 20257:00 amRNSHolding(s) in Company
12th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
22nd Apr 20257:00 amRNSHolding(s) in Company
8th Apr 20257:00 amRNSHolding(s) in Company
28th Feb 20255:00 pmRNSHolding(s) in Company
25th Feb 20257:00 amRNSHalf-year Report
18th Feb 20256:15 pmRNSHolding(s) in Company
11th Feb 20254:40 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTrading Statement
29th Nov 20247:00 amRNSSuccessful Completion of Refinancing
18th Nov 20241:10 pmRNSDirector/PDMR Shareholding
18th Nov 20241:09 pmRNSDirector/PDMR Shareholding
15th Nov 20241:10 pmRNSDirector/PDMR Shareholding
12th Nov 20246:36 pmRNSResult of Annual General Meeting
12th Nov 20247:00 amRNSAGM Trading Update
6th Nov 20243:53 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20243:48 pmRNSDirector/PDMR Shareholding
8th Oct 20246:25 pmRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSAnnual Financial Report
1st Oct 20245:30 pmRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20243:38 pmRNSDirector/PDMR Shareholding
20th Sep 20245:17 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.